Search Results - "Lopez Bernal, Jamie"

Refine Results
  1. 1

    Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England by Andrews, Nick, Stowe, Julia, Kirsebom, Freja, Toffa, Samuel, Sachdeva, Ruchira, Gower, Charlotte, Ramsay, Mary, Lopez Bernal, Jamie

    Published in Nature medicine (01-04-2022)
    “…Booster vaccination with messenger RNA (mRNA) vaccines has been offered to adults in England starting on 14 September 2021. We used a test-negative…”
    Get full text
    Journal Article
  2. 2

    SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England by Ismail, Sharif A, Saliba, Vanessa, Lopez Bernal, Jamie, Ramsay, Mary E, Ladhani, Shamez N

    Published in The Lancet infectious diseases (01-03-2021)
    “…Understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and transmission in educational settings is crucial for ensuring the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study by Kirsebom, Freja Cordelia Møller, Andrews, Nick, Stowe, Julia, Ramsay, Mary, Lopez Bernal, Jamie

    Published in The Lancet infectious diseases (01-11-2023)
    “…Bivalent BA.1 booster vaccines were offered to adults aged 50 years or older and clinically vulnerable people as part of the 2022 autumn COVID-19 booster…”
    Get full text
    Journal Article
  10. 10

    Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design by Stowe, Julia, Tessier, Elise, Zhao, H, Guy, Rebecca, Muller-Pebody, Berit, Zambon, Maria, Andrews, Nick, Ramsay, Mary, Lopez Bernal, Jamie

    Published in International journal of epidemiology (03-05-2021)
    “…Abstract Background The impact of SARS-CoV-2 alongside influenza is a major concern in the northern hemisphere as winter approaches. Methods Test data for…”
    Get full text
    Journal Article
  11. 11

    Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England by Kirsebom, Freja Cordelia Møller, Andrews, Nick, Sachdeva, Ruchira, Stowe, Julia, Ramsay, Mary, Lopez Bernal, Jamie

    Published in Nature communications (12-12-2022)
    “…Despite the availability of the ChAdOx1-S booster vaccine, little is known about the real-world effectiveness although clinical trials have demonstrated…”
    Get full text
    Journal Article
  12. 12

    COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England by Mensah, Anna A., Stowe, Julia, Jardine, Jennifer E., Kirsebom, Freja C. M., Clare, Tom, Kall, Meaghan, Campbell, Helen, LopezBernal, Jamie, Andrews, Nick

    “…ABSTRACT Objective Assessment of COVID‐19 vaccine safety in pregnancy using population‐based data. Design Matched case–control study nested in a retrospective…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 by Singanayagam, Anika, Patel, Monika, Charlett, Andre, Lopez Bernal, Jamie, Saliba, Vanessa, Ellis, Joanna, Ladhani, Shamez, Zambon, Maria, Gopal, Robin

    “…Severe acute respiratory syndrome coronavirus 2 viral load in the upper respiratory tract peaks around symptom onset and infectious virus persists for 10 days…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study by Stowe, Julia, Andrews, Nick, Kirsebom, Freja, Ramsay, Mary, Bernal, Jamie Lopez

    Published in Nature communications (30-09-2022)
    “…The Omicron variant has been associated with reduced vaccine effectiveness (VE) against mild disease with rapid waning. Meanwhile Omicron has also been…”
    Get full text
    Journal Article